References
Price TJ, Beeke C, Ullah S, et al. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? Cancer. 2015;121:830–5.
Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-RAS mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008;359:1757–65.
Sasaki K, Margonis GA, Wilson A, et al. Prognostic implication of KRAS status after hepatectomy for colorectal liver metastases varies according to primary colorectal tumor location. Ann Surg Oncol. 2016;23:3736–43.
Margonis GA, Amini N, Buettner S, et al. The prognostic impact of primary tumor site differs according to the KRAS mutational status: a study by the international genetic consortium for colorectal liver metastasis. Ann Surg. 2019. https://doi.org/10.1097/SLA.0000000000003504.
Kim HS, Lee JM, Kim HS, et al. Prognosis of synchronous colorectal liver metastases after simultaneous curative-intent surgery according to primary tumor location and KRAS mutational status. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-09041-0.
Yang SY, Cho MS, Kim NK. Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype. Expert Rev Anticancer Ther. 2018;18:351–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors have no conflict of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
ASO Author Reflections is a brief invited commentary on the article, “Prognosis of synchronous colorectal liver metastases after simultaneous curative-intent surgery according to primary tumor location and KRAS mutational status.”
Rights and permissions
About this article
Cite this article
Kim, H.S., Kim, N.K. ASO Author Reflections: Poorest Survival Outcomes in Patients with Right Colon Cancer with KRAS Mutation After Simultaneous Curative-Intent Surgery for Colorectal Cancer Liver Metastases. Ann Surg Oncol 27, 5159–5160 (2020). https://doi.org/10.1245/s10434-020-09047-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-09047-8